A potential role of somatostatin and its receptor SSTR4 in the migration of hepatic oval cells.
Somatostatin (SST) is a regulatory peptide that activates G protein-coupled receptors comprised of five members (somatostatin receptors (SSTRs) 1-5). Despite the broad use of SST and its analogs in clinical practice, the spectrum of SST activities has been incompletely defined. Recently, it has been demonstrated that SST can be a chemoattractant for hematopoietic precursor cells. Since hepatic oval cells (HOCs) share common characteristics with hematopoietic stem cells, we hypothesized that SST could act as a chemoattractant for HOCs by stimulating SSTRs. Reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blot assay revealed an increased expression of SST in the 2-acetyl-aminofluorene (2AAF)/partial hepatectomy (PHx) HOC induction model. Immunohistochemical staining showed the expression of SST in 2AAF/PHx-treated rat liver, as compared to normal liver. Proliferation and migration assays demonstrated that the increase of SST was related to migration of HOCs, but not their proliferation. RT-PCR and quantitative real-time PCR showed that SSTR4 was preferentially expressed by HOCs. Western blot assay and immunohistochemical staining confirmed the expression of SSTR4 by HOCs. In addition, pretreatment with anti-SSTR4 antibody cultures resulted in a dramatic reduction of cell migration as compared to that of control. Lastly, SST stimulated the rearrangement of actin filaments in HOCs, while HOCs treated with anti-SSTR4 antibody failed to do so. These results suggest a positive role for SST in the migration of HOCs, and that this effect is mediated through SSTR4.
Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL 32610-0275, USA.
Youngmi
Y
Jung
Seh-Hoon
SH
Oh
Donghang
D
Zheng
Thomas D
TD
Shupe
Rafal P
RP
Witek
Bryon E
BE
Petersen
D015073:2-Acetylaminofluorene / Q000494:pharmacology; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D002273:Carcinogens / Q000494:pharmacology; D049109:Cell Proliferation; D002478:Cells, Cultured; D002633:Chemotaxis; D004195:Disease Models, Animal; D006498:Hepatectomy; D022781:Hepatocytes / Q000187:drug effects / Q000502:physiology*; D008099:Liver / Q000166:cytology / Q000187:drug effects; D008297:Male; D008565:Membrane Proteins / Q000276:immunology / Q000378:metabolism*; D051381:Rats; D011916:Rats, Inbred F344; D017481:Receptors, Somatostatin / Q000276:immunology / Q000378:metabolism*; D013004:Somatostatin / Q000502:physiology*
D000906:Antibodies; D002273:Carcinogens; D008565:Membrane Proteins; D017481:Receptors, Somatostatin; C098681:somatostatin receptor subtype-4; D013004:Somatostatin; D015073:2-Acetylaminofluorene